Xention's Series D Round

Xention raised a round of funding on November 24, 2010.

Xention is a Cambridge-based biopharmaceutical company specialising in the discovery and development of ion channel-modulating drugs. The Company has potential breakthrough drugs for atrial fibrillati…

Articles about Xention's Series D Round: